<?xml version="1.0" encoding="UTF-8"?><meta xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns="http://www.w3.org/1999/xhtml" xmlns:xi="http://www.w3.org/2001/XInclude" http-equiv="Content-Type" content="text/html; charset=utf-8" />
<style xmlns:fo="http://www.w3.org/1999/XSL/Format" xmlns:xi="http://www.w3.org/2001/XInclude" type="text/css">
   @media screen{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .tds_obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:95%
   }
   .test-story-main table tbody tr td{
   font-size: 110%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   font-size:100%;
   }
   .test-story-main fieldset{
   text-align:center;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   
   }
   .test-story-main table th{
   border:2px groove;
   
   }
   .test-story-main table td{
   border:1px groove;
   
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:center;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .title{
   text-align:left;
   }
   .test-story-main h3{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .pgBrk{
   padding-top:15px;
   }
   .test-story-main .er7Msg{
   width:100%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
   
   @media print{
   .test-story-main legend{
   text-align:center;
   font-size:110%;
   font-weight:bold;
   }
   .test-story-main .nav-tabs{
   font-weight:bold;
   }
   .test-story-main .obxGrpSpl{
   background:#B8B8B8;
   }
   .test-story-main maskByMediaType{
   display:table;
   }
   .test-story-main table tbody tr th{
   font-size:90%
   }
   .test-story-main table tbody tr td{
   font-size:90%;
   }
   .test-story-main table tbody tr th{
   text-align:left;
   background:#C6DEFF;
   
   }
   .test-story-main table thead tr th{
   text-align:center;
   background:#4682B4;
   
   }
   .test-story-main fieldset{
   text-align:center;
   page-break-inside:avoid;
   }
   .test-story-main table{
   width:98%;
   border:1px groove;
   table-layout:fixed;
   margin:0 auto;
   page-break-inside:avoid;
   border-collapse:collapse;
   }
   .test-story-main table tr{
   border:2px groove;
   }
   .test-story-main table th{
   border:2px groove;
   }
   .test-story-main table td{
   border:1px groove;
   }
   .test-story-main table thead{
   border:1px groove;
   background:#446BEC;
   text-align:left;
   }
   .test-story-main .separator{
   background:rgb(240, 240, 255);
   text-align:left;
   }
   .test-story-main table tbody tr td{
   text-align:left;
   }
   .test-story-main .noData{
   background:#B8B8B8;
   }
   .test-story-main .childField{
   background:#B8B8B8;
   }
   .test-story-main .tds_title{
   text-align:left;
   margin-bottom:1%
   }
   .test-story-main h3{
   text-align:center;
   }
   .test-story-main h2{
   text-align:center;
   }
   .test-story-main h1{
   text-align:center;
   }
   .test-story-main .tds_pgBrk{
   page-break-after:always;
   }
   .test-story-main #er7Message table{
   border:0px;
   width:80%
   }
   .test-story-main #er7Message td{
   background:#B8B8B8;
   font-size:65%;
   margin-top:6.0pt;
   border:0px;
   text-wrap:preserve-breaks;
   white-space:pre;
   }
   .test-story-main .er7Msg{
   width:100%;
   font-size:80%;
   }
   .test-story-main .er7MsgNote{
   width:100%;
   font-style:italic;
   font-size:80%;
   }
   .test-story-main .embSpace{
   padding-left:15px;
   }
   .test-story-main .embSubSpace{
   padding-left:25px;
   }
   .test-story-main .accordion-heading{
   font-weight:bold;
   font-size:90%;
   }
   .test-story-main .accordion-heading i.fa:after{
   content:"\00a0 ";
   }
   .test-story-main panel{
   margin:10px 5px 5px 5px;
   }
   }
</style>
<!-- generated by TestStory_v1.xslt Version:1.0   Profile:TestStory-->
<fieldset>
	<div class="test-story-main">
		<tabset>
			<tab heading="FULL"  vertical="false">
				<div class="panel-body">
					<div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>The adverse reaction to the Influenza vaccination of rash within 14 days of dose is reported to the Immunization Registry using a Z22/VXU message.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>No Comments</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>An adverse reaction to the Influenza vaccination of rash within 14 days of dose is recorded in the EMR.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>The adverse reaction has been transmitted to the IIS.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p><strong>Transmit Standard Patient Immunization History Report:&nbsp;</strong>The EHR or other clinical software system directly or indirectly through an intermediary creates and transmits a report of a patient&#39;s newly administered or newly identified immunization history to public health immunization registries.</p><p><strong>Identify Adverse Event:&nbsp;</strong>The EHR or other clinical software system enables capture of structured data regarding adverse events.</p><p><strong>Notify Public Health Immunization Registry (IIS) of Update from Adverse Event:&nbsp;</strong>The EHR or other clinical software system notifies the public health immunization registry (IIS) of an update due to an adverse event.</p><p><strong>Link Standard Codes to Immunization Data:</strong> The EHR or other clinical software system links standard codes (i.e., LOINC for lab tests or evaluation tools, SNOMED CT for conditions or observations, NDC codes for current immunizations, CVX for historical immunizations, appropriate codes for administration site, route, method, etc.) to discrete data elements associated with an immunization.</p><p>Note: Testing for NDC codes, CVX for immunizations.</p><p><br></p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>The VXU/Z22 message passes validation using the NIST Immunization VXU Validation Tool (Z22) (context-free). The content of the message correctly reflects the test data (context-based) in accordance with the Test Data Specification and the Message Content.</p><p>The test data anticipates that only the updated vaccine is included in the message transmitted to the registry. Due to variation in practice, it is acceptable for the message to include only vaccinations with updated content or a broader vaccination history. The tester should document instances where the updated message includes additional vaccine information.</p></td></tr></table></div><br/><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p>The tester verifies that the message includes &#39;U&#39; in RXA 21 for the Influenza vaccine.</p><p>The test data anticipates that the only the updated vaccine is included in the message transmitted to the registry. Due to variation in practice, it is acceptable for the message to include only vaccinations with updated content or a broader vaccination history.The tester should document instances where the updated message includes additional vaccine information.</p><p>All NDC coded values are required to use the 11-Character format that includes dashes (&lsquo;-&lsquo;).</p><p><br></p><p><br></p></td></tr></table></div><br/>
				</div>
			</tab>
			<tab heading="Description" vertical="false"><div class="panel-body"><table><tr><th>Description</th></tr><tr><td><p>The adverse reaction to the Influenza vaccination of rash within 14 days of dose is reported to the Immunization Registry using a Z22/VXU message.</p></td></tr></table></div></tab><tab heading="Comments" vertical="false"><div class="panel-body"><table><tr><th>Comments</th></tr><tr><td><p>No Comments</p></td></tr></table></div></tab><tab heading="Pre-condition" vertical="false"><div class="panel-body"><table><tr><th>Pre-condition</th></tr><tr><td><p>An adverse reaction to the Influenza vaccination of rash within 14 days of dose is recorded in the EMR.</p></td></tr></table></div></tab><tab heading="Post-Condition" vertical="false"><div class="panel-body"><table><tr><th>Post-Condition</th></tr><tr><td><p>The adverse reaction has been transmitted to the IIS.</p></td></tr></table></div></tab><tab heading="Test Objectives" vertical="false"><div class="panel-body"><table><tr><th>Test Objectives</th></tr><tr><td><p><strong>Transmit Standard Patient Immunization History Report:&nbsp;</strong>The EHR or other clinical software system directly or indirectly through an intermediary creates and transmits a report of a patient&#39;s newly administered or newly identified immunization history to public health immunization registries.</p><p><strong>Identify Adverse Event:&nbsp;</strong>The EHR or other clinical software system enables capture of structured data regarding adverse events.</p><p><strong>Notify Public Health Immunization Registry (IIS) of Update from Adverse Event:&nbsp;</strong>The EHR or other clinical software system notifies the public health immunization registry (IIS) of an update due to an adverse event.</p><p><strong>Link Standard Codes to Immunization Data:</strong> The EHR or other clinical software system links standard codes (i.e., LOINC for lab tests or evaluation tools, SNOMED CT for conditions or observations, NDC codes for current immunizations, CVX for historical immunizations, appropriate codes for administration site, route, method, etc.) to discrete data elements associated with an immunization.</p><p>Note: Testing for NDC codes, CVX for immunizations.</p><p><br></p></td></tr></table></div></tab><tab heading="Evaluation Criteria" vertical="false"><div class="panel-body"><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>The VXU/Z22 message passes validation using the NIST Immunization VXU Validation Tool (Z22) (context-free). The content of the message correctly reflects the test data (context-based) in accordance with the Test Data Specification and the Message Content.</p><p>The test data anticipates that only the updated vaccine is included in the message transmitted to the registry. Due to variation in practice, it is acceptable for the message to include only vaccinations with updated content or a broader vaccination history. The tester should document instances where the updated message includes additional vaccine information.</p></td></tr></table></div></tab><tab heading="Notes" vertical="false"><div class="panel-body"><table><tr><th>Notes</th></tr><tr><td><p>The tester verifies that the message includes &#39;U&#39; in RXA 21 for the Influenza vaccine.</p><p>The test data anticipates that the only the updated vaccine is included in the message transmitted to the registry. Due to variation in practice, it is acceptable for the message to include only vaccinations with updated content or a broader vaccination history.The tester should document instances where the updated message includes additional vaccine information.</p><p>All NDC coded values are required to use the 11-Character format that includes dashes (&lsquo;-&lsquo;).</p><p><br></p><p><br></p></td></tr></table></div></tab>
		</tabset>
	</div>
</fieldset>